Placebo-Controlled Trial of Pharmaceutical Optimized Hydralazine 25mg (F-6) in Patients with Essential Hypertension. mfm. 2024;30(5). Accessed November 16, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/3666